13F filer · CIK 1352851 ↗

Magnetar Financial LLC

You are looking at Q2 2022. See the latest, Q2 2026 →

Reported value

$9.67B

+3.2% on the quarter before

Positions

1,661

733 new · 380 sold out

Top 10

23.2%

of the value

Est. gain

−$142.3M

on stocks held all quarter

Est. return

−2.4%

on those stocks since Q1 2022

Filed

Aug 15, 2022

On SEC EDGAR ↗

Positions as of Jun 30, 2022, from Magnetar Financial LLC's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

  • New
  • Added
  • Cut
  • Same
  • Options

The 24 largest positions, 37% of the reported value, each sized by its share, colored by what the fund did with it since Q1 2022. Striped tiles are options.

Valaris Ltd9.9%
Coherent Inc1.7%
Change Healthcare Inc1.7%
Sanderson Farms Inc1.6%
Vmware Inc1.5%
Shaw Communications Inc1.5%
Black Knight Inc1.4%
Lhc Group Inc1.4%
Pnm Res Inc1.3%
Mandiant Inc1.2%
Welbilt Inc1.2%
Cmc Materials Inc1.1%
Duke Realty Corp1.1%
Rogers Corp1.1%
Churchill Capital Corp Vii1.1%
Activision Blizzard Inc1.1%
First Horizon Corporation1.0%
Boston Scientific Corp1.0%
Yamana Gold Inc1.0%
Meritor Inc1.0%
Biohaven Pharmactl Hldg Co L0.9%
Gcp Applied Technologies Inc0.9%
Avantor Inc0.8%
Baxter Intl Inc0.8%

Largest buys

Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Valaris Ltd~$953.6MNew · 0.0% → 9.9%+22,576 shares
  2. Vmware Inc~$146.0MNew · 0.0% → 1.5%+1,280,977 shares
  3. Black Knight Inc~$132.0MAdded · 0.0% → 1.4%+2,017,955 shares
  4. Duke Realty Corp~$108.8MNew · 0.0% → 1.1%+1,980,867 shares
  5. Yamana Gold Inc~$96.3MNew · 0.0% → 1.0%+20,709,773 shares
  6. Biohaven Pharmactl Hldg Co L~$86.1MNew · 0.0% → 0.9%+591,216 shares
  7. Turning Point Therapeutics I~$69.5MNew · 0.0% → 0.7%+923,581 shares
  8. Sierra Oncology Inc~$60.9MNew · 0.0% → 0.6%+1,106,649 shares
  9. Boston Scientific Corp~$48.9MAdded · 0.6% → 1.0%+1,312,294 shares
  10. Lhc Group Inc~$47.9MAdded · 1.0% → 1.4%+307,401 shares

Largest sells

Since Q1 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

  1. Cerner Corp~$186.2MSold out · 2.0% → 0.0%−1,990,607 shares
  2. Peoples United Financial Inc~$129.7MSold out · 1.4% → 0.0%−6,488,105 shares
  3. Mgm Growth Pptys Llc~$124.4MSold out · 1.3% → 0.0%−3,215,039 shares
  4. Zynga Inc~$122.6MSold out · 1.3% → 0.0%−13,265,133 shares
  5. Ferro Corp~$109.4MSold out · 1.2% → 0.0%−5,030,563 shares
  6. Us Ecology Inc~$97.5MSold out · 1.0% → 0.0%−2,035,717 shares
  7. Veoneer Inc~$92.8MSold out · 1.0% → 0.0%−2,510,707 shares
  8. Activision Blizzard Inc~$74.1MCut · 1.9% → 1.1%−952,285 shares
  9. Intersect Ent Inc~$71.1MSold out · 0.8% → 0.0%−2,537,735 shares
  10. Ortho Clinical Diagnostics H~$67.9MSold out · 0.7% → 0.0%−3,639,599 shares

Holdings

As of Jun 30, 2022. Changes are in shares against Mar 31, 2022, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
HoldingValue
Valaris LtdCOM CL A · shares New9.9%$953.6M—
Coherent IncCOM · shares −6.8% · price −2.6%1.7%$168.3M−$4.5M
Change Healthcare IncCOM · shares −2.9% · price +5.8%1.7%$167.4M+$9.1M
Sanderson Farms IncCOM · shares −8.5% · price +15.0%1.6%$155.2M+$20.2M
Vmware IncCL A COM · shares New1.5%$146.0M—
Shaw Communications IncCL B CONV · shares −6.9% · price −5.0%1.5%$141.5M−$7.5M
Black Knight IncCOM · shares +2,728% · price +12.8%1.4%$136.8M+$547,565
Lhc Group IncCOM · shares +55% · price −7.6%1.4%$135.6M−$7.2M
Pnm Res IncCOM · shares −7.2% · price +0.2%1.3%$128.1M+$294,824
Mandiant IncCOM · shares −6.9% · price −2.2%1.2%$112.2M−$2.5M
Welbilt IncCOM · shares −28% · price +0.3%1.2%$112.0M+$282,786
Cmc Materials IncCOM · shares −18% · price −5.9%1.1%$111.1M−$6.9M
Duke Realty CorpCOM NEW · shares New1.1%$108.8M—
Rogers CorpCOM · shares −26% · price −3.5%1.1%$104.6M−$3.8M
Churchill Capital Corp ViiUNIT 99/99/9999 · shares −4.3% · price −0.5%1.1%$103.3M−$523,759
Activision Blizzard IncCOM · shares −42% · price −2.8%1.1%$102.0M−$2.9M
First Horizon CorporationCOM · shares −38% · price −6.9%1.0%$100.0M−$7.5M
Boston Scientific CorpCOM · shares +100% · price −15.9%1.0%$98.1M−$9.3M
Yamana Gold IncCOM · shares New1.00%$96.3M—
Meritor IncCOM · shares −25% · price +2.1%0.98%$94.7M+$2.0M
Biohaven Pharmactl Hldg Co LCOM · shares New0.89%$86.1M—
Gcp Applied Technologies IncCOM · shares −6.3% · price −0.4%0.87%$83.8M−$374,926
Avantor IncCOM · shares +56% · price −8.0%0.83%$79.8M−$4.5M
Baxter Intl IncCOM · shares +58% · price −17.2%0.82%$79.1M−$10.3M
Plantronics Inc NewCOM · shares −7.2% · price +0.7%0.76%$73.2M+$516,213
Total · 1,661 positions100%$9.67B−$142.3M
The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q1 2022 to Q2 2022: 904 stocks held throughout, down $142.3M (−2.4%).

  1. Sanderson Farms Inc+$20.2M+15%
  2. Change Healthcare Inc+$9.1M+6%
  3. Merck & Co Inc+$4.7M+11%
  4. Cigna Corp New+$3.1M+10%
  5. Lucid Group Inc+$2.4M+38%
  6. First Horizon Corporation−$7.5M−7%
  7. Shaw Communications Inc−$7.5M−5%
  8. Horizon Therapeutics Pub L−$7.6M−24%
  9. Boston Scientific Corp−$9.3M−16%
  10. Baxter Intl Inc−$10.3M−17%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 6 splits read into the share counts.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$30.00B$15.00B$0
Q1 2016Q2 2026
Every quarter's filing
Each quarter's 13F filing, newest first
QuarterReported valueFiling
Q2 2026$10.96B+11%SEC ↗
Q1 2026$9.84B−4%SEC ↗
Q4 2025$10.21B−38%SEC ↗
Q3 2025$16.50B−20%SEC ↗
Q2 2025$20.65B+171%SEC ↗
Q1 2025$7.61B+75%SEC ↗
Q4 2024$4.36B−6%SEC ↗
Q3 2024$4.62B−4%SEC ↗
Q2 2024$4.80B+7%SEC ↗
Q1 2024$4.47B+13%SEC ↗
Q4 2023$3.94B+1%SEC ↗
Q3 2023$3.92B−14%SEC ↗
Q2 2023$4.56B−11%SEC ↗
Q1 2023$5.13B−13%SEC ↗
Q4 2022$5.91B−18%SEC ↗
Q3 2022$7.21B−25%SEC ↗
Q2 2022$9.67B+3%SEC ↗
Q1 2022$9.37B−6%SEC ↗
Q4 2021$9.96B+1%SEC ↗
Q3 2021$9.82B−7%SEC ↗
Q2 2021$10.56B+2%SEC ↗
Q1 2021$10.40B+47%SEC ↗
Q4 2020$7.08B+25%SEC ↗
Q3 2020$5.66B+67%SEC ↗
Q2 2020$3.39B−18%SEC ↗
Q1 2020$4.15B−13%SEC ↗
Q4 2019$4.79B+22%SEC ↗
Q3 2019$3.93B−21%SEC ↗
Q2 2019$5.00B+29%SEC ↗
Q1 2019$3.89B−5%SEC ↗
Q4 2018$4.08B−26%SEC ↗
Q3 2018$5.54B−16%SEC ↗
Q2 2018$6.56B+13%SEC ↗
Q1 2018$5.80B+3%SEC ↗
Q4 2017$5.62B+2%SEC ↗
Q3 2017$5.52B−15%SEC ↗
Q2 2017$6.52B−7%SEC ↗
Q1 2017$7.02B+1,897%SEC ↗
Q4 2016$351.5M−95%SEC ↗
Q3 2016$7.03B+17%SEC ↗
Q2 2016$6.02B−7%SEC ↗
Q1 2016$6.49BSEC ↗

Get the newsletter

The day's AI and market news, in your inbox every weekday.